|
MechanismCbl-b inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Comprehensive Cancer Center of Wake Forest University
0 Patents (Medical) associated with Comprehensive Cancer Center of Wake Forest University
100 Deals associated with Comprehensive Cancer Center of Wake Forest University
100 Translational Medicine associated with Comprehensive Cancer Center of Wake Forest University